NO752650L - - Google Patents

Info

Publication number
NO752650L
NO752650L NO752650A NO752650A NO752650L NO 752650 L NO752650 L NO 752650L NO 752650 A NO752650 A NO 752650A NO 752650 A NO752650 A NO 752650A NO 752650 L NO752650 L NO 752650L
Authority
NO
Norway
Prior art keywords
general formula
compound
condensed
fluorophenyl
chlorophenyl
Prior art date
Application number
NO752650A
Other languages
English (en)
Norwegian (no)
Inventor
D Rahtz
H Wendt
H Koch
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO752650L publication Critical patent/NO752650L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10Radicals substituted by halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO752650A 1974-07-29 1975-07-28 NO752650L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2436883A DE2436883C2 (de) 1974-07-29 1974-07-29 Benzimidazol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
NO752650L true NO752650L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-01-30

Family

ID=5922047

Family Applications (1)

Application Number Title Priority Date Filing Date
NO752650A NO752650L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1974-07-29 1975-07-28

Country Status (25)

Country Link
US (1) US4011322A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS5136468A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR207869A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT346336B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU8347175A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE831856A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BG (1) BG26374A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1065866A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH615924A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CS (1) CS189713B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD122536A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2436883C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK140634B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES439811A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FI (1) FI752152A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2280380A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1520262A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HU170517B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE41503B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL47769A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL7509061A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO752650L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE7508544L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SU (1) SU626698A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA754884B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093726A (en) * 1976-12-02 1978-06-06 Abbott Laboratories N-(2-benzimidazolyl)-piperazines
JPS59199679A (ja) * 1983-04-27 1984-11-12 Kanebo Ltd 新規なベンズイミダゾ−ル誘導体、その製造法およびその医薬組成物
CA2132528C (en) * 1992-03-23 2004-06-08 Gerard Frans Maria Jan Cauwenbergh Agent for use as an anti-irritant
DE102006007773B4 (de) * 2006-02-20 2010-02-11 Walter Dr. Kothe Anordnung zum Spalten von Wasser
AR066165A1 (es) * 2007-09-18 2009-07-29 Univ Stanford Metodos de tratamiento de una infeccion viral de la familia flaviviridae, composiciones para el tratamiento de una infeccion viral de la familia flaviviridae y ensayos de control para identificar composiciones para el tratamiento de una infeccion viral de la familia flaviviridae
US9101628B2 (en) * 2007-09-18 2015-08-11 The Board Of Trustees Of The Leland Stanford Junior University Methods and composition of treating a flaviviridae family viral infection
US9149463B2 (en) * 2007-09-18 2015-10-06 The Board Of Trustees Of The Leland Standford Junior University Methods and compositions of treating a Flaviviridae family viral infection
US8940730B2 (en) 2007-09-18 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions of treating a Flaviviridae family viral infection
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
EP2408449A4 (en) * 2009-03-18 2012-08-08 Univ Leland Stanford Junior METHOD AND COMPOSITIONS FOR TREATING FLAVIVIRIDAE VIRUS INFECTIONS
BR112012024289A2 (pt) 2010-03-26 2017-07-18 Galderma Res & Dev "método para fornecer um tratamento seguro e efetivo do eritema e composição de gel tópica"
KR20140091543A (ko) 2011-10-19 2014-07-21 갈데르마 소시에떼아노님 전신용인 포스포디에스터레이즈타입-5-억제제에 의한 안면홍조를 경감시키는 방법
WO2015026849A1 (en) 2013-08-19 2015-02-26 The Regents Of The University Of California Compounds and methods for treating an epileptic disorder
ES2920886T3 (es) 2015-02-25 2022-08-11 Univ California Agonistas de 5HT para el tratamiento de trastornos epilépticos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1620449C3 (de) * 1964-07-23 1974-02-21 Schering Ag, 1000 Berlin Und 4619 Bergkamen Substituierte Benzimidazole und Verfahren zu ihrer Herstellung
GB1209558A (en) * 1968-07-06 1970-10-21 Delalande Sa Derivatives of 5-cinnamoyl benzofuran and process for their preparation

Also Published As

Publication number Publication date
GB1520262A (en) 1978-08-02
DK140634C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-03-10
ES439811A1 (es) 1977-04-16
FR2280380A1 (fr) 1976-02-27
SU626698A3 (ru) 1978-09-30
IE41503L (en) 1976-01-29
ATA583775A (de) 1978-03-15
SE7508544L (sv) 1976-01-30
IL47769A0 (en) 1975-10-15
AR207869A1 (es) 1976-11-08
DE2436883A1 (de) 1976-02-19
FR2280380B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-04-30
DD122536A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-10-12
IE41503B1 (en) 1980-01-16
CA1065866A (en) 1979-11-06
DK344575A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-01-30
AU8347175A (en) 1977-02-03
NL7509061A (nl) 1976-02-02
CS189713B2 (en) 1979-04-30
DK140634B (da) 1979-10-15
HU170517B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-06-28
ZA754884B (en) 1976-06-30
IL47769A (en) 1978-10-31
DE2436883C2 (de) 1985-08-22
BG26374A3 (bg) 1979-03-15
BE831856A (fr) 1976-01-29
AT346336B (de) 1978-11-10
CH615924A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1980-02-29
JPS5136468A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-03-27
FI752152A7 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-01-30
US4011322A (en) 1977-03-08

Similar Documents

Publication Publication Date Title
NO752650L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR850000883B1 (ko) 삼-치환 이미다졸 유도체의 제조방법
US4407824A (en) Pharmaceutical preparations for topical application which contain salts of alkanecarboxylic acids, novel carboxylic acid salts and the production thereof
DE69500597T2 (de) N-pyridyl Carboxamidderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutischen Zusammensetzungen
FR2555584A1 (fr) Derives de l'acide fluoro-6-dihydro-1,4-oxo-4-piperazinyl substitue-7-quinoline-carboxylique-3 et procede pour leur preparation et compositions pharmaceutiques a action anti-bacteriennes a base desdits derives
US5229378A (en) Glycyrrhetic acid derivatives
JPH06211737A (ja) 疾患の治療のための置換シクロヘキサン誘導体
FR2705095A1 (fr) Nouveaux indoles substitués, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
NZ194328A (en) 3-amino-1-(phenyl or pyridyl)-2-pyrazolines:pharmaceutical compositions
NO141207B (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive fenylalkylaminer
TWI383795B (zh) 皮膚炎治療劑
US4970301A (en) 2-(piperazinyl)-2-oxoethylene-substituted flavonoid compounds
US9345678B2 (en) Prostanoid receptor agonist compounds and methods of use for same
FR2472561A1 (fr) Derives de l'acide 4-guanidinomethylcyclohexane carboxylique, leur procede de preparation et leur application en therapeutique
NO824335L (no) Fremgangsmaate for fremstilling av farmakologisk aktive fenolestere.
LU82584A1 (fr) Nouvelles phenoxyamines heterocycliques substituees,leur methode de preparation et leur application comme anesthesiques locaux
NO793578L (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive trifenylalkenderivater
KR100327270B1 (ko) 디아자시클로알킨알킬술폰아미드유도체
EP0079639B1 (en) A new anti-inflammatory drug
KR20240036571A (ko) 치료 화합물 및 방법
CA2278660A1 (en) Hydroquinone derivatives
DK158944B (da) Analogifremgangsmaade til fremstilling af substituerede methylimidazolforbindelser
CA2166032A1 (fr) Derives de 1-oxo-2-(phenylsulfonylamino) pentylpiperidine, leur preparation et leur application en therapeutique
EP0496746A1 (en) Pharmaceutically active amino-substituted heteroaryl amines
US4259335A (en) 1-Methyl-4-piperidinol esters of 4-quinolinylamino benzoates and antiinflammatory and analgesic compositions and methods employing them